Allstate
ALL
$257.87
+0.03%
The Allstate Corporation is a major US property and casualty insurer, offering personal auto, homeowners, and other insurance products through a network of approximately 6,000 exclusive agents. As one of the largest insurers in the US, Allstate holds a strong competitive position in the personal lines market, distinguished by its extensive agency distribution and brand recognition. Currently, the stock is in focus due to a favorable catastrophe loss environment, which has boosted earnings, and the company's ability to benefit from higher interest rates through improved investment yields. Investors are also monitoring its growth initiatives and capital return programs, as evidenced by recent dividend declarations and analyst attention.…
ALL
Allstate
$257.87
Related headlines
Investment Opinion: Should I buy ALL Today?
Based on the analysis, Allstate is rated a 'Hold' with a slight bullish tilt. The consensus analyst rating is 'hold' with an average target price of $274.09, implying a 5.2% upside from the current price of $260.58. The thesis is that Allstate's strong current earnings and cheap valuation provide a margin of safety, but the sustainability of these earnings is uncertain, warranting a cautious stance.
Sign up to view all
ALL 12-Month Price Forecast
The AI assessment is neutral with medium confidence. Allstate's current earnings are exceptionally strong, but the market's cautious outlook on sustainability is reflected in the forward PE. The stock offers a good risk/reward for value investors, but the lack of strong growth catalysts and the potential for earnings normalization limit upside. If catastrophe losses remain low and the company continues to execute, the stock could re-rate higher, but this is uncertain. A key factor to watch is the Q3 earnings report, which will provide clarity on the sustainability of underwriting margins.
Wall Street consensus
Most Wall Street analysts maintain a constructive view on Allstate's 12-month outlook, with a consensus price target around $274.09 and implied upside of +6.3% versus the current price.
Average Target
$274.09
0 analysts
Implied Upside
+6.3%
vs. current price
Analyst Count
—
covering this stock
Price Range
$176 - $334
Analyst target range
Allstate is covered by 22 analysts, with a consensus recommendation of 'hold' and a mean rating of 2.52 (where 1 is strong buy and 5 is sell). The average target price is $274.09, implying an upside of 5.2% from the current price of $260.58. The distribution of ratings is not provided, but the 'hold' consensus suggests a neutral stance. The target price range is wide, from a low of $176.00 to a high of $334.00, indicating significant uncertainty about the stock's future. The high target implies a 28.2% upside, likely assuming continued favorable underwriting and growth, while the low target suggests a 32.5% downside, possibly pricing in a return of catastrophe losses or competitive pressures. Recent ratings actions have been mixed, with HSBC downgrading from Buy to Hold, while others like JP Morgan and Evercore have maintained Overweight/Outperform ratings, reflecting divergent views on the sustainability of current earnings.
Drowning in data?
Find the real signal!
Bulls vs Bears: ALL Investment Factors
Allstate presents a compelling value proposition with exceptional current earnings, a strong balance sheet, and defensive characteristics. However, the market's cautious outlook on earnings sustainability, reflected in the wide gap between trailing and forward PE, introduces significant uncertainty. The bull case is supported by the current favorable underwriting environment and cheap valuation, while the bear case hinges on a potential normalization of catastrophe losses and limited revenue growth. The most critical tension is whether the current earnings level is sustainable; if catastrophe losses remain low, the stock is undervalued, but if they revert to historical norms, the stock could face a significant de-rating. Currently, the evidence slightly favors the bull case given the strong balance sheet and low valuation, but the risk is elevated.
Bullish
- Exceptional earnings rebound: Q1 2026 net income surged to $2.46B from $0.60B a year ago, with net margin expanding from 3.66% to 14.51%. This reflects a dramatic improvement in underwriting, driven by a benign catastrophe environment and rate increases.
- Undervalued on forward earnings: Forward PE of 9.44x is a 37% discount to the industry average of 15x. Even with earnings normalization, the stock appears cheap relative to peers, offering a margin of safety.
- Strong balance sheet and cash flow: Debt-to-equity is a conservative 0.24, and free cash flow over the TTM is $11.53B, comfortably covering dividends and buybacks. ROE is an impressive 33.59%, indicating efficient capital use.
- Defensive characteristics: Beta of 0.156 is significantly lower than the market, making ALL a defensive holding. Its 1-year return of +27.89% outpaced the S&P 500's +18.56%, providing both stability and growth.
Bearish
- Earnings sustainability questioned: Forward PE of 9.44x is significantly higher than trailing PE of 5.38x, implying the market expects earnings to decline from current peak levels. This is likely due to a normalization of catastrophe losses, which could compress margins.
- High valuation risk near 52-week high: The stock trades at 94% of its 52-week range, close to the high of $277.22. This leaves limited upside and increases the risk of a pullback, especially if earnings disappoint.
- Mixed analyst ratings: Consensus is 'hold' with a mean rating of 2.52, and HSBC recently downgraded from Buy to Hold. This reflects uncertainty about the sustainability of current earnings and growth prospects.
- Low current ratio: Current ratio of 0.37 is typical for insurers but indicates reliance on investment income for liquidity. In a stressed scenario, this could pose a risk if investment yields decline.
ALL Technical Analysis
Allstate's stock has demonstrated a robust uptrend over the past year, with a 1-year price change of +27.89%, significantly outperforming the S&P 500's +18.56% over the same period. The current price of $260.58 sits at 94.0% of its 52-week range (low of $188.08, high of $277.22), indicating the stock is trading near its highs, reflecting strong momentum and investor confidence, though it also raises the risk of overextension. The stock's beta of 0.156 suggests it is significantly less volatile than the market, which is atypical for an insurer and may indicate a defensive characteristic.
Beta
0.16
0.16x market volatility
Max Drawdown
-11.5%
Largest decline past year
52-Week Range
$188-$277
Price range past year
Annual Return
+26.7%
Cumulative gain past year
| Period | ALL Return | S&P 500 |
|---|---|---|
| 1m | -2.4% | +2.0% |
| 3m | +23.2% | +1.0% |
| 6m | +21.9% | +11.8% |
| 1y | +26.7% | +18.1% |
| ytd | +26.5% | +11.7% |
Bobby - Your AI Investment Partner
Get real-time data, AI-driven personalized investment analysis to make smarter investment decisions
ALL Fundamental Analysis
Allstate's revenue has shown steady growth, with the most recent quarter (Q1 2026) reporting revenue of $16.94 billion, a 4.17% increase year-over-year. This growth is supported by a multi-quarter trend of increasing revenue, from $15.62 billion in Q2 2024 to $16.94 billion in Q1 2026, indicating a consistent upward trajectory. The company's profitability is robust, with a net income of $2.46 billion in Q1 2026, translating to a net margin of 14.51%, and a gross margin of 45.33%, which is strong for the insurance industry. These margins have expanded significantly from the prior year, where Q1 2025 had a net margin of only 3.66%, reflecting improved underwriting performance and lower catastrophe losses. Allstate's balance sheet is solid, with a debt-to-equity ratio of 0.24, indicating conservative leverage, and a strong free cash flow of $11.53 billion over the trailing twelve months, which comfortably covers its dividend and share repurchases. The company's return on equity is an impressive 33.59%, demonstrating efficient capital utilization, and its current ratio of 0.37 is typical for insurers, which rely on investment income rather than current assets for liquidity.
Quarterly Revenue
$16.9B
2026-03
Revenue YoY Growth
+4.2%
YoY Comparison
Gross Margin
45.3%
Latest Quarter
Free Cash Flow
$11.5B
Last 12 Months
Revenue & Net Income Trends (2 Years)
Revenue Breakdown
Open an Account, get $2 TSLA now!
Valuation Analysis: Is ALL Overvalued?
Given Allstate's positive net income, the PE ratio is the appropriate valuation metric. The trailing PE is 5.38x, while the forward PE is 9.44x, indicating that the market expects earnings to decline from the current elevated levels, likely due to a normalization of catastrophe losses. The gap between trailing and forward PE suggests a cautious outlook on earnings sustainability. Compared to the industry, Allstate's forward PE of 9.44x is at a discount to the sector average of 15x, representing a 37% discount, which may be justified by its lower growth prospects relative to some peers. Historically, Allstate's trailing PE has ranged from 3.58x to 35.21x over the past two years, with the current 5.38x near the lower end, suggesting the stock is undervalued relative to its own history, but this could also reflect the market's concern about peak earnings. The PEG ratio of 0.04 is extremely low, indicating the stock is cheap relative to its growth rate, but this is skewed by the high current earnings.
PE
5.4x
Latest Quarter
vs. Historical
Low-End
5-Year PE Range 4x~24x
vs. Industry Avg
N/A
Industry PE ~N/A*
EV/EBITDA
4.4x
Enterprise Value Multiple
Investment Risk Disclosure
Financial and operational risks: Allstate's earnings are highly sensitive to catastrophe losses, which can cause significant volatility. In Q1 2025, net income was only $595 million, while Q1 2026 saw $2.46 billion, illustrating the impact of a benign catastrophe environment. If catastrophe losses return to historical averages, earnings could drop sharply, potentially reverting to levels seen in 2024 when net income was $1.19 billion in Q3. The company's debt-to-equity ratio of 0.24 is conservative, but its current ratio of 0.37 is low, though typical for insurers. Free cash flow of $11.53 billion is strong, but it is partly dependent on investment income, which could be affected by interest rate changes.
